Blaine Davis - Net Worth and Insider Trading
Blaine Davis Net Worth
The estimated net worth of Blaine Davis is at least $1 Million dollars as of 2025-07-02. Blaine Davis is the CFO of Cartesian Therapeutics Inc and owns about 94,811 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $1 Million. Blaine Davis is also the CFO of Protara Therapeutics Inc and owns about 1,481 shares of Protara Therapeutics Inc (TARA) stock worth over $4,147. Details can be seen in Blaine Davis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Blaine Davis has not made any transactions after 2025-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Blaine Davis
Blaine Davis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Blaine Davis owns 2 companies in total, including Protara Therapeutics Inc (TARA) , and Cartesian Therapeutics Inc (RNAC) .
Click here to see the complete history of Blaine Davis’s form 4 insider trades.
Insider Ownership Summary of Blaine Davis
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| TARA | Protara Therapeutics Inc | 2020-09-22 | Chief Financial Officer |
| RNAC | Cartesian Therapeutics Inc | 2025-01-06 | Chief Financial Officer |
Blaine Davis Latest Holdings Summary
Blaine Davis currently owns a total of 2 stocks. Among these stocks, Blaine Davis owns 94,811 shares of Cartesian Therapeutics Inc (RNAC) as of January 6, 2025, with a value of $1 Million and a weighting of 99.6%. Blaine Davis also owns 1,481 shares of Protara Therapeutics Inc (TARA) as of September 22, 2020, with a value of $4,147 and a weighting of 0.4%.
Latest Holdings of Blaine Davis
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics Inc | 2025-01-06 | 94,811 | 10.97 | 1,040,077 |
| TARA | Protara Therapeutics Inc | 2020-09-22 | 1,481 | 2.80 | 4,147 |
Holding Weightings of Blaine Davis
Blaine Davis Form 4 Trading Tracker
According to the SEC Form 4 filings, Blaine Davis has made a total of 1 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cartesian Therapeutics Inc is the sale of 7,989 shares on January 6, 2025, which brought Blaine Davis around $134,055.
According to the SEC Form 4 filings, Blaine Davis has made a total of 1 transactions in Protara Therapeutics Inc (TARA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Protara Therapeutics Inc is the acquisition of 1,481 shares on September 22, 2020, which cost Blaine Davis around $25,044.
Insider Trading History of Blaine Davis
- 1
Blaine Davis Trading Performance
GuruFocus tracks the stock performance after each of Blaine Davis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Blaine Davis is 36.28%. GuruFocus also compares Blaine Davis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Blaine Davis within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Blaine Davis's insider trading performs compared to the benchmark.
Performance of Blaine Davis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.91 | | | | | |
| Relative Return to S&P 500(%) | 22.75 | | | | | |
Blaine Davis Ownership Network
Ownership Network List of Blaine Davis
Ownership Network Relation of Blaine Davis
Blaine Davis Owned Company Details
What does Protara Therapeutics Inc do?
Who are the key executives at Protara Therapeutics Inc?
Blaine Davis is the Chief Financial Officer of Protara Therapeutics Inc. Other key executives at Protara Therapeutics Inc include Sr. Vice President & Research Jacqueline Zummo , 10 percent owner Opaleye Management Inc. , and Chief Financial Officer Patrick Fabbio .
Protara Therapeutics Inc (TARA) Insider Trades Summary
Over the past 18 months, Blaine Davis made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. , a net purchase of 40,000 shares made by Richard S Levy , and a net sale of 21,224 shares made by Jacqueline Zummo .
In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 40,000 shares, with a net purchase of 40,000 shares. During the past 18 months, 724,684 shares of Protara Therapeutics Inc (TARA) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 684,684 shares.
Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protara Therapeutics Inc Insider Transactions
Blaine Davis Mailing Address
Above is the net worth, insider trading, and ownership report for Blaine Davis. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Blaine Davis's mailing address is: New York Ny 10014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
